Risk of severe illness of COVID-19 patients with NAFLD and increased NAFLD fibrosis scores

by Cheng, J., Huang, R., Huang, S., Li, C., Li, M., Li, Y., Liu, J., Liu, L., Wang, J., Wu, C., Xue, L., Xue, R., Yao, R., Zhao, H., Zhao, X.-A, Zhu, C., Zhu, L.
Published 2021

The association between rs1260326 with the risk of NAFLD and the mediation effect of triglyceride on NAFLD in the elderly Chinese Han population

by Bi, Y., Gu, Z., He, G., Liu, B.-C, Niu, W., Ren, D., Yuan, F., Yuan, R., Zhang, L.
Published 2022

Using the theoretical domains framework to identify barriers and enabling factors to implementation of guidance for the diagnosis and management of nonalcoholic fatty liver disease...

by Anstee, Q.M, Avery, L., Dombrowski, S.U, Hallsworth, K., McPherson, S.
Published 2021

Prevalence of Fatty Liver Disease is Driven by Prediabetes and Diabetes: US NHANES 2017–2018

by Claypool, K., Patel, C.J
Published 2022

Effect of Endoscopic Bariatric and Metabolic Therapies on Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis

by Dolan, R.D, Jirapinyo, P., McCarty, T.R, Shah, R., Thompson, C.C
Published 2022

Combined metabolic activators therapy ameliorates liver fat in nonalcoholic fatty liver disease patients

by Akyildiz, M., Altay, O., Arif, M., Borén, J., Fredolini, C., Gonenli, M.G, Kim, W., Li, X., Mardinoglu, A., Nielsen, J., Saglam, B., Schwenk, J.M, Shoaie, S., Uhlén, M., Ural, D., Yang, H., Zeybel, M., Zhang, C.
Published 2021

Ferritin as a key risk factor for nonalcoholic fatty liver disease in children with obesity

by Cao, J., Dong, G., Fu, J., Huang, K., Wu, W., Xu, H., Ye, J., Zhang, J.
Published 2021

Non-invasive Assessment of Liver Fat in ob/ob Mice Using Ultrasound-Induced Thermal Strain Imaging and Its Correlation with Hepatic Triglyceride Content

by Delany, J.P, Farhat, N., Jarnagin, J., Khalid, W.B, Kim, K., Lavery, L.
Published 2021

Use of a convolutional neural network and quantitative ultrasound for diagnosis of fatty liver

by Do, M.N, Miller, R.J, Nguyen, T.N, Oelze, M.L, Park, T.H, Podkowa, A.S
Published 2021

Non-alcoholic fatty liver disease in patients with type 2 diabetes in Greenland: a register-based cross-sectional study

by Gantzel, R.H, Grønbæk, H., Hansen, F.O, Muhammad, A.G, Pedersen, M.L, Rex, K.F, Villadsen, G.E
Published 2022

Advancing the global public health agenda for NAFLD: a consensus statement

by Åberg, F., Adams, L., Allen, A.M, Alnaser, F., Alqahtani, S.A, Alswat, K., Alvares-da-Silva, M.R, Alvaro, D., Andrade, R.J, Anstee, Q.M, Arab, J.P, Arrese, M., Awuku, Y.A, Ayesha, M., Baatarkhuu, O., Bakieva, S., Basu, R., Bataller, R., Batterham, R.L, Bedri, S., Bosi, E., Bourliere, M., Bruha, R., Bugianesi, E., Burra, P., Buti, M., Byrne, C.D, Calleja, J.L, Carrieri, P., Carter, F., Castera, L., Castillo-Lopez, G., Castro-Narro, G.E, Chan, H.L.Y, Chan, W.-K, Chang, Y., Colombo, M., Coppell, K.J, Corey, K., Cortez-Pinto, H., Craxi, A., Crespo, J., Cryer, D., Cusi, K., Dassanayake, A., de Ledinghen, V., de Oliveira, C.P.M.S, DelPrato, S., Demaio, A., Desalegn, H., Dillon, J., Dirac, M.A, Dorairaj, P., Duseja, A., Ekstedt, M., El Kassas, M., Elsanousi, O.M, Esmat, G., Fan, J.-G, Farpour-Lambert, N., Fernandez, M.I.C, Figueroa, M.P, Flisiak, R., Fouad, Y., Francque, S., Fuchs, M., Gani, R.A, George, J., Gerber, L., Ghazinyan, H., Gheorghe, L., Goh, G.B.-B, Grønbæk, H., Gulnara, A., Hagström, H., Hamid, S., Hebditch, V., Hickman, I.J, Hocking, S.L, Hofmann, W.P, Huang, T.T.-K, Hunyady, B., Idilman, R., Isakov, V.A, Iskandar, N.J, Ismail, M.H, Jamal, M.H, Jepsen, P., Kakizaki, S., Kalamitsis, G., Kanwal, F., Kao, J.-H, Kaplan, L., Kautz, A., Kawaguchi, T., Khader, Y., Khatry, M.S.A, Kim, S.U, Kodjoh, N., Koek, G., Koike, K., Komas, N.P, Korenjak, M., Kugelmas, M., Labidi, A., Lange, N.F, Lavine, J.E, Lazarus, J.V, Lazo, M., Lee, N., Lesmana, C.R.A, Liu, C.-J, Long, M.T, Loomba, R., Lopez-Jaramillo, P., Macedo, M.P, Mahtab, M.A, Malekzadeh, R., Marchesini, G., Marinho, R., Mark, H.E, Martins, A.A.S, Mateva, L., Melin, P., Mikolasevic, I., Miller, V., Milovanovic, T., Murillo, O.A, Musso, C., Naamani, K.A, Nakajima, A., Nava, E., Nersesov, A.V, Newsome, P.N, Nikolova, D., Ninburg, M., Nlombi, C.M, Norris, S., Novak, K., Oben, J., Ocama, P., Ong, J.P, Onyekwere, C., Pan, C.Q, Papatheodoridis, G., Paruk, I., Patel, K., Penha-Gonçalves, C., Petta, S., Puri, P., Rac, M., Ralston, J., Ramji, A., Ratziu, V., Razavi, H., Rinella, M., Roberts, S., Roden, M., Romero, D., Romero-Gómez, M., Rose, T., Rouabhia, S., Rovere-Querini, P., Rowe, I.A, Sadirova, S., Salupere, R., Saparbu, T., Sarin, S.K, Sayegh, R., Schattenberg, J.M, Sebastiani, G., Seki, Y., Selmo, J., Serme, A.K, Shaw, J.E, Shawa, I.T, Shenoy, T., Sheriff, D.S, Sheron, N., Shibolet, O., Silva, M., Skrypnyk, I., Socha, P., Song, M.J, Soriano, J., Spearman, C.W, Sridharan, K., Suárez, J.J, Sudhamshu, K.C, Sung, K.-C, Swain, M., Tacke, F., Taheri, S., Tan, S.-S, Tapper, E.B, the NAFLD Consensus Consortium, Thiele, M., Tolmane, I., Torres, E.A, Trauner, M., Treeprasertsuk, S., Tsochatzis, E.A, Turcanu, A., Valantinas, J., Valenti, L., Vázquez, S.E.M, Vesterhus, M., Waked, I., Wild, S.H, Willemse, J., Wong, R.J, Wong, V.W.-S, Xanthakos, S., Yilmaz, Y., Yki-Järvinen, H., Young, D.Y, Younossi, Z.M, Yu, M.-L, Zelber-Sagi, S., Zeybel, M., Zheng, K.I, Zheng, M.-H
Published 2022

The Relationship Between Body Fat Distribution and Nonalcoholic Fatty Liver in Adults With Type 1 Diabetes. Diabetes Care 2021;44:1706–1713

by Dahlstr€Om, E.H, Forsblom, C., Gordin, D., Groop, P.-H, Harjutsalo, V., Inkeri, J., Mutter, S., Parente, E.B, Sandholm, N.
Published 2022

Liquid biomarkers for fibrotic NASH – progress in a complex field

by Myneni, S., Schuppan, D., Surabattula, R.
Published 2022

ADAMTSL2 protein and a soluble biomarker signature identify at-risk non-alcoholic steatohepatitis and fibrosis in adults with NAFLD

by Corey, K.E, Finkel, N., Gee, D.W, Gerszten, R.E, Gustafson, J.L, Hutter, M.M, Jacob, J., Jennings, L.L, Lai, M., Loureiro, J., Masia, R., Meireles, O.R, Ngo, D., Osganian, S.A, Pitts, R., Richards, S.M, Ukomadu, C., Wang, T.J, Witkowski, E.R
Published 2022

Significantly higher atherosclerosis risks in patients with obstructive sleep apnea and non-alcoholic fatty liver disease

by Ghani, R.A, Isa, M.R, Ismail, A.I, Johari, B., Koshy, M., Rahman, T.H.A, Razali, M.M, Shah, F.Z.M, Sukahri, S.
Published 2021

Non-alcoholic fatty liver disease (NAFLD) and the cardiovascular disease (CVD) risk categories in primary care: is there an association?

by Hashim, H., Miptah, H.N, Mohamad, M., Ramli, A.S, Tharek, Z.
Published 2020

Fructose-drinking water induced nonalcoholic fatty liver disease and ultrastructural alteration of hepatocyte mitochondria in Male wistar rat

by Haji Suhaimi, F., Mamikutty, N., Thent, Z.C
Published 2015

Genome-wide analysis of copy number variation identifies candidate gene loci associated with the progression of non-alcoholic fatty liver disease

by Anwar, A., Basu, R.C, Chan, W.-K, Cheah, P.-L, Cooper, D.N, Mahadeva, S., Mahfudz, A.S, Mohamed, R., Mohamed, Z., Rampal, S., Razali, R., Rosli, N.S.M, Zain, S.M
Published 2014

Overlooked subclinical portal hypertension in non-cirrhotic NAFLD: Is it real and how to measure it?

by Baffy, G., Bosch, J.
Published 2022

Investigation on the mechanism of Ginkgo Folium in the treatment of Non-alcoholic Fatty Liver Disease by strategy of network pharmacology and molecular docking

by Du, L., Jin, H., Li, S., Sun, Y., Tian, Y., Wang, L., Xiao, X., Yan, S., Yu, H.
Published 2023